SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
18-Nov-24 7:28 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 15-Nov-24 | Option Exercise | 20,000 | $3.23 | $64,600.00 | 109% 18.27K to 38.27K | |
18-Nov-24 7:28 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 15-Nov-24 | Option Sale | 20,000 | $17.14 | $342,888.00 | (52%) 38.27K to 18.27K | |
18-Nov-24 7:28 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 14-Nov-24 | Option Exercise | 35,000 | $3.23 | $113,050.00 | 192% 18.27K to 53.27K | |
18-Nov-24 7:28 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 14-Nov-24 | Option Sale | 35,000 | $16.13 | $564,644.00 | (66%) 53.27K to 18.27K | |
04-Jan-24 5:06 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 02-Jan-24 | Grant | 548,200 | -- | -- | 100% 0 to 548.2K |